Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Aegion Corp - Class A Common Stock
Alpha Cognition Inc
Aprea Therapeutics, Inc. - Common Stock
AutoWeb, Inc. - Common Stock
Berkshire Grey, Inc. - Class A Common Stock
Berry Corporation (bry) - Common Stock
BioCardia, Inc. - Common Stock
California Resources Corporation Common Stock
Capri Holdings Limited Ordinary Shares
Celestica
Centricus Acquisition Corp. - Class A Ordinary Share
ChaSerg Technology Acquisition Corp. - Class A Common Stock
Delek US Holdings, Inc. Common Stock
Direxion Daily Semiconductor Bull 3X ETF
Duos Technologies Group, Inc. - Common Stock
Foresight Acquisition Corp. - Class A Common Stock
Fusemachines Inc. - Common stock
Green Plains, Inc. - Common Stock
Points.com Inc. - Common Shares
PowerFleet, Inc. - Common Stock
Prime Medicine, Inc. - Common Stock
SKYX Platforms Corp. - Common Stock
Scienjoy Holding Corporation - Class A Ordinary Shares
Sustainable Opportunities Acquisition Corp
Synalloy Corporation - Common Stock
Tiziana Life Sciences Ltd - Common Shares
VanEck Robotics ETF
WisdomTree Efficient TIPS Plus Gold Fund
Edit Watchlist
Indicators
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Prime Medicine, Inc.
< Previous
1
2
Next >
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
November 12, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates
November 12, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces Pricing of Public Offering of Common Stock
November 10, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces Proposed $125.0 Million Public Offering of Common Stock
November 10, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Present at Jefferies Global Healthcare Conference
November 09, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
October 05, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency
September 24, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Participate in Upcoming Investor Conferences
September 03, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 06, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
July 23, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
July 08, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
June 22, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
June 18, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference
June 03, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Present at Jefferies Global Healthcare Conference
May 28, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
May 07, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer
April 16, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
March 03, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Participate in Upcoming Investor Conferences
February 25, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference
January 07, 2026
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
December 07, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Present at 8th Annual Evercore Healthcare Conference
November 25, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Present at Jefferies Global Healthcare Conference
November 11, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 07, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 07, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
November 03, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
October 30, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Participate in Upcoming Investor Conferences
October 07, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine to Participate in Upcoming Investor Conferences
August 26, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 07, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today